PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Pegaptanib 300micrograms/0.09ml inj pre-filled syringes
1108020ACAAAAAA
Pegaptanib sodium Pegaptanib sodium Eye No data available
Pegaspargase 3,750units inj vials
0801050BAAAABAB
Pegaspargase Pegaspargase Malignant Disease and Immunosuppression No data available
Pegaspargase 3,750units/5ml solution for injection vials
0801050BAAAAAAA
Pegaspargase Pegaspargase Malignant Disease and Immunosuppression No data available
Pegasys 135micrograms/0.5ml inj pre-filled pens
0802040A0BDACAM
Pegasys Peginterferon alpha Malignant Disease and Immunosuppression No data available
Pegasys 180micrograms/0.5ml inj pre-filled pens
0802040A0BDADAN
Pegasys Peginterferon alpha Malignant Disease and Immunosuppression No data available
Pegasys 180micrograms/0.5ml inj pre-filled syringes
0802040A0BDAAAF
Pegasys Peginterferon alpha Malignant Disease and Immunosuppression No data available
Pegfilgrastim 6mg/0.6ml inj pre-filled disposable devices
0901060P0AAABAB
Pegfilgrastim Pegfilgrastim Nutrition and Blood No data available
Pegfilgrastim 6mg/0.6ml inj pre-filled syringes
0901060P0AAAAAA
Pegfilgrastim Pegfilgrastim Nutrition and Blood No data available
Peginterferon alfa-2a 135micrograms/0.5ml inj pf dispos dev
0802040A0AAAMAM
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2a 135micrograms/0.5ml inj pfs
0802040A0AAAGAG
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2a 180micrograms/0.5ml inj pf dispos dev
0802040A0AAANAN
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2a 180micrograms/0.5ml inj pfs
0802040A0AAAFAF
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2a 90micrograms/0.5ml inj pfs
0802040A0AAAPAP
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 100microgram inj pf dispos dev
0802040A0AAAKAK
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 100microgram inj vials
0802040A0AAABAB
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 120microgram inj pf dispos dev
0802040A0AAAIAI
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 120microgram inj vials
0802040A0AAAEAE
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 150microgram inj pf dispos dev
0802040A0AAAHAH
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 150microgram inj vials
0802040A0AAADAD
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 50microgram inj pf dispos dev
0802040A0AAAJAJ
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 50microgram inj vials
0802040A0AAACAC
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 80microgram inj pf dispos dev
0802040A0AAALAL
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon alfa-2b 80microgram inj vials
0802040A0AAAAAA
Peginterferon A Peginterferon alpha Malignant Disease and Immunosuppression No data available
Peginterferon beta-1a 125micrograms/0.5ml inj pf dispos dev
0802040APAAABAB
Peginterferon B Peginterferon beta Malignant Disease and Immunosuppression No data available
Peginterferon beta-1a 63microg and 94microg/0.5ml inj
0802040APAAAAAA
Peginterferon B Peginterferon beta Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.